Literature DB >> 14528000

Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor.

Ermanno Gherardi1, Mark E Youles, Ricardo N Miguel, Tom L Blundell, Luisa Iamele, Julian Gough, Abhishek Bandyopadhyay, Guido Hartmann, P Jonathan G Butler.   

Abstract

Little is known about the large ectodomain of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor (HGF/SF). Here, we establish by deletion mutagenesis that the HGF/SF and heparin-binding sites of MET are contained within a large N-terminal domain spanning the alpha-chain (amino acids 25-307) and the first 212 amino acids of the beta-chain (amino acids 308-519). Neither the cystine-rich domain (amino acids 520-561) nor the C-terminal half of MET (amino acids 562-932) bind HGF/SF or heparin directly. The MET ectodomain, which behaves as a rod-shaped monomer with a large Stokes radius in solution, binds HGF/SF in the absence or presence of heparin, and forms a stable HGF/SF-heparin-MET complex with 1:1:1 stoichiometry. We also show that the ligand-binding domain adopts a beta-propeller fold, which is similar to the N-terminal domain of alphaV integrin, and that the C-terminal half contains four Ig domains (amino acids 563-654, 657-738, 742-836, and 839-924) of the unusual structural E set, which could be modeled on bacterial enzymes. Our studies provide 3D models and a functional map of the MET ectodomain. They have broad implications for structure-function of the MET receptor and the related semaphorin and plexin proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14528000      PMCID: PMC218709          DOI: 10.1073/pnas.2034936100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.

Authors:  C Wiesmann; M H Ultsch; S H Bass; A M de Vos
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

2.  A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth.

Authors:  L Trusolino; A Bertotti; P M Comoglio
Journal:  Cell       Date:  2001-11-30       Impact factor: 41.582

Review 3.  Novel sequences propel familiar folds.

Authors:  Zahra Jawad; Massimo Paoli
Journal:  Structure       Date:  2002-04       Impact factor: 5.006

4.  Assignment of homology to genome sequences using a library of hidden Markov models that represent all proteins of known structure.

Authors:  J Gough; K Karplus; R Hughey; C Chothia
Journal:  J Mol Biol       Date:  2001-11-02       Impact factor: 5.469

5.  Crystal structure of the extracellular segment of integrin alpha Vbeta3.

Authors:  J P Xiong; T Stehle; B Diefenbach; R Zhang; R Dunker; D L Scott; A Joachimiak; S L Goodman; M A Arnaout
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

6.  The mode of action of heparan and dermatan sulfates in the regulation of hepatocyte growth factor/scatter factor.

Authors:  Malcolm Lyon; Jon A Deakin; John T Gallagher
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

7.  Point mutations identified in Lec8 Chinese hamster ovary glycosylation mutants that inactivate both the UDP-galactose and CMP-sialic acid transporters.

Authors:  S Oelmann; P Stanley; R Gerardy-Schahn
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

8.  Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.

Authors:  D Lietha; D Y Chirgadze; B Mulloy; T L Blundell; E Gherardi
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

9.  Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.

Authors:  Thomas P J Garrett; Neil M McKern; Meizhen Lou; Thomas C Elleman; Timothy E Adams; George O Lovrecz; Hong-Jian Zhu; Francesca Walker; Morry J Frenkel; Peter A Hoyne; Robert N Jorissen; Edouard C Nice; Antony W Burgess; Colin W Ward
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

10.  The semaphorin 4D receptor controls invasive growth by coupling with Met.

Authors:  Silvia Giordano; Simona Corso; Paolo Conrotto; Stefania Artigiani; Giorgio Gilestro; Davide Barberis; Luca Tamagnone; Paolo M Comoglio
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

View more
  59 in total

Review 1.  To move or not to move? Semaphorin signalling in cell migration.

Authors:  Luca Tamagnone; Paolo M Comoglio
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

Review 2.  Targeting MET in cancer: rationale and progress.

Authors:  Ermanno Gherardi; Walter Birchmeier; Carmen Birchmeier; George Vande Woude
Journal:  Nat Rev Cancer       Date:  2012-01-24       Impact factor: 60.716

Review 3.  Targeting the HGF/Met signaling pathway in cancer therapy.

Authors:  Fabiola Cecchi; Danie C Rabe; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

4.  Steric hindrance effects on surface reactions: applications to BIAcore.

Authors:  David A Edwards
Journal:  J Math Biol       Date:  2007-05-25       Impact factor: 2.259

Review 5.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 6.  MET targeted therapy for lung cancer: clinical development and future directions.

Authors:  Yan Feng; Patrick C Ma
Journal:  Lung Cancer (Auckl)       Date:  2012-08-09

7.  Structural basis for agonism and antagonism of hepatocyte growth factor.

Authors:  W David Tolbert; Jennifer Daugherty-Holtrop; Ermanno Gherardi; George Vande Woude; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

8.  The regulatory role of heparin on c-Met signaling in hepatocellular carcinoma cells.

Authors:  Evin İşcan; Aysim Güneş; Peyda Korhan; Yeliz Yılmaz; Esra Erdal; Neşe Atabey
Journal:  J Cell Commun Signal       Date:  2016-12-14       Impact factor: 5.782

9.  HGF and MET mutations in primary and secondary lymphedema.

Authors:  David N Finegold; Vivien Schacht; Mark A Kimak; Elizabeth C Lawrence; Etelka Foeldi; Jenny M Karlsson; Catherine J Baty; Robert E Ferrell
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

10.  Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein.

Authors:  Zuzana Berkova; Shu Wang; Jillian F Wise; Hoyoung Maeng; Yuan Ji; Felipe Samaniego
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.